SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-6EF - Registration of American Depository Receipt shares, immediately effective:
SEC Accession No. 0001193805-16-003643
Filing Date
2016-07-28
Accepted
2016-07-28 06:02:07
Documents
6
Effectiveness Date
2016-07-28

Document Format Files

Seq Description Document Type Size
1 e615168_f6ef-adaptimmune.htm F-6EF 127583
2 e615168_ex99-a.htm EX-99.(A) 621359
3 e615168_ex99-b.htm EX-99.(B) 178052
4 e615168_ex99-d.htm EX-99.(D) 15171
5 e615168_ex99-e.htm EX-99.(E) 6664
6 GRAPHIC pbwtlogo.jpg GRAPHIC 15072
  Complete submission text file 0001193805-16-003643.txt   971381
Mailing Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013
Business Address 388 GREENWICH STREET, 14TH FLOOR NEW YORK NY 10013 212-816-6647
Citibank,N.A./ADR (Filed by) CIK: 0001472033 (see all company filings)

IRS No.: 521568099 | State of Incorp.: DC | Fiscal Year End: 1231
Type: F-6EF

Mailing Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY
Business Address 101 PARK DRIVE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RY 44 1235 430000
Adaptimmune Therapeutics PLC (Subject) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 0630
Type: F-6EF | Act: 33 | File No.: 333-212714 | Film No.: 161788197
SIC: 2836 Biological Products, (No Diagnostic Substances)